REFERENCES
- Dragic T, Litwin V, Allaway GP, Martin SR, Huang YX, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667–73.
- Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al. CC CkR5: a RANTES, MIP-1a, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272: 1955–8.
- Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 391: 661–6.
- Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, et al. The β-chemokine receptors CCR3 and CCR5 faciliate infection by primary HIV-1 isolates. Cell 1996; 85: 1135–48.
- Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptor CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85: 1149–58.
- Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856–62.
- Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, et al. Resistance to HIV-1 infection in Caucassian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–5.
- Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367–77.
- Biti R, Ffrench R, Young J, Benetts B, Stewart G, Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med 1997; 3: 252–3.
- Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990; 132: 847–56.
- Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-bp deletion. Nature Gen 1997; 16: 100–3.
- Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, et al. Dating the origin of the CCR5-delta 32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 1998; 62: 1507–15.
- Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240–3.
- Jiang JD, Wang Y, Roboz J, Strauchen J, Holland JF, Bekesi JG. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound. Cancer Res 1998; 58: 2126–33.
- Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, et al. Detection of mammary tumor virus ENV gene-like sequences in human breast cancer. Cancer Res 1995; 55: 5173–9.
- Wang Y, Go V, Holland JF, Melana S, Pogo BG-T. Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer. Clin Cancer Res 1998; 4: 2565–8.
- Mummidi S, Ahuja SS, McDaniel BL, Ahuja SK. The human CC chemokine receptor 5 (CCR5) gene: multiple transcripts with 5′-end heterogeneity, dual promotor usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 1997; 272: 30662–71.
- Yu Esh, Xie QY, Zhang KL, Lu P, Chan LL. HIV infection and AIDS in China 1985 through 1994. Am J Pub Health 1996; 86: 1116–22.
- Ministry of Health, PR China and UN Theme Group on HIV/AIDS in China: China responds to AIDS: HIV/AIDS situation and needs assessment report. 1997.
- Yu XF, Chen J, Shao YM, Beyrer C, Lai SH. Two subtypes of HIV-1 among injection-drug users in southern China. Lancet 1998; 351: 1250.
- Luo CC, Tian C, Hu DJ, Kai M, Dondero TJ, Zheng XW, et al. HIV-1 subtype C in China. Lancet 1995; 345: 1051–2.
- Cheng H, Zhang J, Capizzi J, Young NL, Mastro TD. HIV-1 subtype E in Yunnan. Lancet 1994; 344: 953–4.
- Zhang L, Huang Y, He T, Cao Y, Ho D. HIV-1 subtype and second-receptor use. Nature 1996; 383: 768.
- Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A, et al. The deltaccr5 mutation conferring protection against HIV-1 in Caucasion populations has a single and recent origin in Northeastern Europe. Hum Mol Genet 1998; 7: 399–406.
- Husian S, Goila R, Shahi S, Banerjea A. First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor CCR5 gene. Gene 1998; 207: 141–7.